1140 материалов по теме, собраны автоматически из проверенных источников
A protein known as p53 is, of all tumor suppressors in human cancer, the most frequently altered by gene mutations. When mutations cause it to be absent or nonfunctional, its loss can allow populations of mutant cells to expand through normal tissue. Researchers have long known that loss of p53 does more than remove a…
Scientists at the Montreal Clinical Research Institute (IRCM), led by Université de Montréal medical professor Javier Di Noia, have shed light on a fundamental mystery in immunology: How do immune cells manage to concentrate a powerful mutagenic enzyme at precisely defined regions of DNA while largely sparing the rest…
HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted. The series of initiatives is designed to eliminate duplication, ensure more efficient enrollment and provide patients with earlier access to promising therapies. “The goal is straightforward —…
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials Urology Times
The 5 Most Impactful Phase 3 Cancer Trial Results From September 2026 Cure Today
UMass Cancer Walk raises more than $500,000 for cancer research UMass Chan Medical School
Policy review demands better quality of life data in cancer clinical trials News-Medical
A new study by scientists at City of Hope and TGen, part of City of Hope, found surprisingly large differences in the number of mutations present in the organs of healthy individuals. Some study participants had mutation counts similar to those typically found in cancer patients. These results provide an explanation…
City of Hope and TGen study finds hidden mutation rates may shape cancer risk EurekAlert! Science News Releases
BostonGene Chief Medical Officer to Discuss Biologically Grounded AI and Multimodal Data in Oncology Drug Development at the 2nd Annual Global Cancer Research & Innovation Symposium BioSpace
A noninvasive neurosurgical procedure that delivers radiation to a specific brain pathway significantly reduced symptoms of major depression among people with severe, treatment-resistant psychiatric illness, study results showed. Stereotactic radiosurgical (SRS) capsulotomy also led to a significant reduction in…
Addition of a “simple” clinical risk score on top of current risk assessment tools may improve identification of patients undergoing chemotherapy likely to develop treatment-related cardiotoxicity, researchers reported. The use of the novel RE-ACT score on top of the Heart Failure Association-International…
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer | Newswise Newswise
BostonGene Chief Medical Officer to Discuss Biologically Grounded AI and Multimodal Data in Oncology Drug Development at the 2nd Annual Global Cancer Research & Innovation Symposium Yahoo Finance
ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer PR Newswire